Insiders · CNSP

CNSP insider transactions

CNS Pharmaceuticals Inc. (CNSP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

CNSP insiders

Everyone who has filed a Form 3, 4, 5 or 144 at CNS Pharmaceuticals Inc., latest first. Follow anyone to get their next filing.

• Michal FisherDirector, since May 2026+$10K
• Rami LevinCEO and President, since January 2026
• Faith L. CharlesDirector, since December 2022+$34K
• Eric FaulknerChief Technology Officer, since March 2026
• Steve O'LoughlinChief Financial Officer, since March 2026
• Jeffry R. KeyesDirector
• Amy MaheryDirector, since February 2024
• John M ClimacoChief Executive Officer, Director+$65.4K
• Christopher DownsChief Financial Officer+$74K
• Bettina M. CockroftDirector, since May 2023
• Jerzy GumulkaDirector+$19.6K
• Cortice Biosciences, Inc.10% owner, since July 2024
• Carl Anthony EvansDirector+$10,000
• Andrzej AndraczkeDirector
• Waldemar Priebe10% owner-$133K

Recent Form 3, 4, and 5 filings for CNSP

• 87d
  Director Fisher Michal bought $10,000 worth of shares (2,000 units at $5.00) (SEC Form 4)

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 87d
  CEO and President Levin Rami decreased direct ownership by 50% to 4,750 units (SEC Form 4)

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 87d
  SEC Form 3 filed by new insider Fisher Michal

  3 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 177d
  Director Charles Faith L. bought $34,002 worth of shares (7,100 units at $4.79) (SEC Form 4)

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 253d
  SEC Form 4 filed by Chief Technology Officer Faulkner Eric

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 253d
  SEC Form 3 filed by new insider Faulkner Eric

  3 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 253d
  SEC Form 4 filed by Chief Financial Officer O'Loughlin Steve

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 253d
  SEC Form 3 filed by new insider O'Loughlin Steve

  3 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 314d
  SEC Form 4 filed by CEO and President Levin Rami

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 314d
  SEC Form 3 filed by new insider Levin Rami

  3 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 358d
  SEC Form 4 filed by Director Keyes Jeffry R.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 358d
  SEC Form 4 filed by Chief Executive Officer Climaco John M

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 358d
  SEC Form 4 filed by Director Charles Faith L.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 358d
  SEC Form 4 filed by Director Mahery Amy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 358d
  SEC Form 4 filed by Chief Financial Officer Downs Christopher

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 358d
  SEC Form 4 filed by Director Gumulka Jerzy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 358d
  SEC Form 4 filed by Director Cockroft Bettina M.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 829d
  SEC Form 4 filed by Large owner Cortice Biosciences, Inc.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 829d
  New insider Cortice Biosciences, Inc. claimed ownership of 573,368 shares (SEC Form 3)

  3 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 946d
  SEC Form 4 filed by Mahery Amy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 946d
  SEC Form 4 filed by Keyes Jeffry R.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 946d
  SEC Form 4 filed by Gumulka Jerzy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 946d
  SEC Form 4 filed by Evans Carl Anthony

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 946d
  SEC Form 4 filed by Downs Christopher

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 946d
  SEC Form 4 filed by Cockroft Bettina M.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 946d
  SEC Form 4 filed by Climaco John M

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 946d
  SEC Form 4 filed by Charles Faith L.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1011d
  SEC Form 4 filed by Mahery Amy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1011d
  Gumulka Jerzy bought $10,000 worth of shares (33,333 units at $0.30), increasing direct ownership by 345% to 43,006 units (SEC Form 4)

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1011d
  Evans Carl Anthony bought $10,000 worth of shares (33,333 units at $0.30), increasing direct ownership by 26,666% to 33,458 units (SEC Form 4)

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1011d
  Downs Christopher bought $20,000 worth of shares (66,666 units at $0.30), increasing direct ownership by 181% to 103,438 units (SEC Form 4)

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1011d
  Climaco John M bought $50,000 worth of shares (166,666 units at $0.30), increasing direct ownership by 340% to 215,676 units (SEC Form 4)

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1011d
  SEC Form 3 filed by new insider Mahery Amy

  3 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1127d
  SEC Form 4 filed by Gumulka Jerzy (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1127d
  SEC Form 4 filed by Evans Carl Anthony (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1127d
  SEC Form 4 filed by Keyes Jeffry R. (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1127d
  SEC Form 4 filed by Charles Faith L. (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1127d
  SEC Form 4 filed by Cockroft Bettina M. (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1127d
  SEC Form 4 filed by Andraczke Andrzej (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1144d
  SEC Form 4 filed by Keyes Jeffry R.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1144d
  SEC Form 4 filed by Gumulka Jerzy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1144d
  SEC Form 4 filed by Evans Carl Anthony

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1144d
  SEC Form 4 filed by Cockroft Bettina M.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1144d
  SEC Form 4 filed by Charles Faith L.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1144d
  SEC Form 4 filed by Andraczke Andrzej

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1178d
  SEC Form 4: Downs Christopher bought $34,177 worth of shares (27,000 units at $1.27), increasing direct ownership by 276% to 36,772 units

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1185d
  SEC Form 4: Climaco John M bought $4,944 worth of shares (2,750 units at $1.80), increasing direct ownership by 6% to 49,010 units

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1190d
  SEC Form 4 filed by Cockroft Bettina M. (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1200d
  SEC Form 4: Priebe Waldemar sold $133,114 worth of shares (94,298 units at $1.41)

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1284d
  SEC Form 4 filed by Cockroft Bettina M.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1284d
  SEC Form 3 filed by new insider Cockroft Bettina M.

  3 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1291d
  SEC Form 4 filed by Climaco John M

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1291d
  SEC Form 4 filed by Downs Christopher

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1302d
  SEC Form 4 filed by Gumulka Jerzy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1305d
  SEC Form 4 filed by Downs Christopher

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1306d
  SEC Form 4 filed by Gumulka Jerzy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1309d
  SEC Form 4 filed by Climaco John M

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1322d
  SEC Form 4 filed by Climaco John M

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1322d
  SEC Form 4 filed by Downs Christopher

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1409d
  SEC Form 4 filed by Charles Faith L.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)